Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc Announces Executive Leadership Changes


Monday, 9 Sep 2013 06:00am EDT 

Albany Molecular Research Inc announced that Dr. Thomas E. D'Ambra, Ph.D. will retire as President and Chief Executive Officer of the Company, effective December 31, 2013. Dr. D'Ambra will be named the Company's non-executive Chairman of the Board of Directors on the same date. Mr. Bill Marth, will succeed Tom as President and Chief Executive Officer of AMRI. 

Company Quote

18.99
-0.09 -0.47%
27 Apr 2015